| Literature DB >> 27903747 |
Miranda M Sung1, Ty T Kim1, Emmanuel Denou2, Carrie-Lynn M Soltys1, Shereen M Hamza1, Nikole J Byrne1, Grant Masson1, Heekuk Park3, David S Wishart4, Karen L Madsen3, Jonathan D Schertzer2, Jason R B Dyck5.
Abstract
Oral administration of resveratrol is able to improve glucose homeostasis in obese individuals. Herein we show that resveratrol ingestion produces taxonomic and predicted functional changes in the gut microbiome of obese mice. In particular, changes in the gut microbiome were characterized by a decreased relative abundance of Turicibacteraceae, Moryella, Lachnospiraceae, and Akkermansia and an increased relative abundance of Bacteroides and Parabacteroides Moreover, fecal transplantation from healthy resveratrol-fed donor mice is sufficient to improve glucose homeostasis in obese mice, suggesting that the resveratrol-mediated changes in the gut microbiome may play an important role in the mechanism of action of resveratrol.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27903747 DOI: 10.2337/db16-0680
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461